• No results found

Long-Acting Injection

Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection

Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection

... and long-acting injectable “depot” preparations of antipsychotic medications have been used as an alternative to oral medication therapy for patients for whom adherence is a clinically significant problem, ...

11

Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons

Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons

... risperidone long-acting injection study most similar to the single olanzapine long-acting injection study that was ...risperidone long-acting injection ...

8

A pooled analysis of injection site related adverse events in patients with schizophrenia treated with olanzapine long acting injection

A pooled analysis of injection site related adverse events in patients with schizophrenia treated with olanzapine long acting injection

... Olanzapine long-acting injection (LAI) is a depot an- tipsychotic formulation consisting of a pamoate salt of olanzapine that is administered by deep intramuscular in- jection every 2 to 4 weeks ...

5

Emerging treatments in the management of bipolar disorder – focus on risperidone long acting injection

Emerging treatments in the management of bipolar disorder – focus on risperidone long acting injection

... Risperidone long acting injection (RLAI) as a monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder was approved by Food and Drug ...

10

Dose associated changes in safety and efficacy parameters observed in a 24 week maintenance trial of olanzapine long acting injection in patients with schizophrenia

Dose associated changes in safety and efficacy parameters observed in a 24 week maintenance trial of olanzapine long acting injection in patients with schizophrenia

... Olanzapine long-acting injection (LAI) has been studied in both the short-term [1] and long-term [2] treatment of ...have long been observed [6]. Among atypical depots, risperidone ...

10

Risperidone long acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada

Risperidone long acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada

... Background: Depot formulations of antipsychotics provide a potential solution to the poor adherence to oral therapies in schizophrenia. However, there have been few comparative studies on the effectiveness and ...

9

A critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorder

A critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorder

... a long-acting injection (LAI) addresses adherence issues, thus potentially reducing ...a long-term, double-blind, randomized, controlled trial of adult patients (n=334; intent-to-treat [ITT]) ...

8

Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia

Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia

... Olanzapine long-acting injection (OLAI) is a crystalline salt composed of olanzapine and pamoic acid, which permits a depot intramuscular formulation of ...a long-term, controlled trial of 24 ...

9

Preparation and in vitro/in vivo evaluation of PLGA microspheres containing norquetiapine for long-acting injection

Preparation and in vitro/in vivo evaluation of PLGA microspheres containing norquetiapine for long-acting injection

... The SEM images of NQ ⋅ 2HCl, NQ freebase, PLGA 502, PLGA 502H, and NQ freebase PLGA 502H microspheres are shown in Figure 1. NQ ⋅ 2HCl was shown to have an angular, crystalline form (Figure 1A). NQ freebase microspheres ...

9

Treatment and control of bovine hypodermosis with ivermectin long acting injection (IVOMEC® GOLD)

Treatment and control of bovine hypodermosis with ivermectin long acting injection (IVOMEC® GOLD)

... Conclusions: The results from this study demonstrate that ivermectin in a long-acting formulation is 100 % efficacious in the treatment of cattle naturally infested by H. bovis and H. lineatum larvae at all ...

6

Pharmacogenetic evaluation to assess breakthrough psychosis with aripiprazole long acting injection: a case report

Pharmacogenetic evaluation to assess breakthrough psychosis with aripiprazole long acting injection: a case report

... new long-acting injectable formulation of ari- piprazole, aripiprazole lauroxil, was considered due higher dosing options (aripiprazole lauroxil 882 mg every 4- weeks, equivalent to aripiprazole LAI 600 mg) ...

7

Post injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long acting injection, I: analysis of cases

Post injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long acting injection, I: analysis of cases

... proper injection technique does not guarantee that a blood vessel injury has not occurred during the injection process, it is therefore necessary to observe the patient following each ...each ...

10

Olanzapine long acting injection: a review of first experiences of post injection delirium/sedation syndrome in routine clinical practice

Olanzapine long acting injection: a review of first experiences of post injection delirium/sedation syndrome in routine clinical practice

... in-hospital injection (22 cases) remained in hospital; it is not known whether these events in themselves would have merited hospital- isation or an extension of ...

8

Post injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long acting injection, II: investigations of mechanism

Post injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long acting injection, II: investigations of mechanism

... equilibrium solubility of the salt could dissolve. Under static conditions, a hematoma consisting of 20 mL blood would appear to be required for the dissolution of approximately 20 mg olanzapine (based upon the 0.986 ...

10

Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia

Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia

... Abstract: A recent meta-analysis showed that long-acting injectable (LAI) antipsychotics were not superior to oral antipsychotics for preventing relapse in patients with schizophrenia. We there- fore ...

5

Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia

Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia

... preferred. Long- acting risperidone is the first such antipsychotic available for use in this vulnerable group of patients and offers an attractive alternative to traditional ...that ...

5

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection

... Methods: This study describes changes in the levels of functioning among outpatients with schizophrenia treated with olanzapine-LAI compared with oral olanzapine over 2 years. This was a secondary analysis of data from a ...

7

Schizophrenia symptoms and functioning in patients receiving long term treatment with olanzapine long acting injection formulation: a pooled analysis

Schizophrenia symptoms and functioning in patients receiving long term treatment with olanzapine long acting injection formulation: a pooled analysis

... The objective of the analyses reported is to evaluate how non-acute schizophrenia patients with different baseline status develop in terms of their symptoms and functioning during maintenance treatment as analyzed by ...

11

Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection

Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection

... patients. Long-acting injectable formulations of second-generation antipsychotics could combine the effect of oral second-generation antipsychotics in patients with bipolar disorder and the benefits of ...

10

Long acting olanzapine versus long acting risperidone for schizophrenia in Spain – a cost effectiveness comparison

Long acting olanzapine versus long acting risperidone for schizophrenia in Spain – a cost effectiveness comparison

... and long-acting injection formulations of risperidone and other antipsychotics for the treatment of non-adherent and partially adherent patients with schizophrenia within the United States healthcare ...

12

Show all 10000 documents...

Related subjects